Total Payments
$1,264
2020 Payments
$117.89
Companies
4
Transactions
102
Medicare Patients
398
Medicare Billing
$29,693
Payment Breakdown by Category
Food & Beverage$1,234 (97.6%)
Education$29.99 (2.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,234 | 101 | 97.6% |
| Education | $29.99 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $488.18 | 85 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $359.97 | 3 | $0 (2017) |
| Allergan Inc. | $315.70 | 5 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $99.67 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $117.89 | 24 | Supernus Pharmaceuticals, Inc. ($117.89) |
| 2019 | $214.61 | 27 | Supernus Pharmaceuticals, Inc. ($141.82) |
| 2018 | $247.73 | 37 | Supernus Pharmaceuticals, Inc. ($217.74) |
| 2017 | $683.29 | 14 | Teva Pharmaceuticals USA, Inc. ($359.97) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 2 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $5.57 | General |
| Category: AED | ||||||
| 09/23/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $4.77 | General |
| Category: AED | ||||||
| 09/16/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $4.44 | General |
| Category: AED | ||||||
| 09/11/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $2.99 | General |
| Category: AED | ||||||
| 09/03/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $2.11 | General |
| Category: AED | ||||||
| 08/26/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $4.20 | General |
| Category: AED | ||||||
| 08/19/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $3.25 | General |
| Category: AED | ||||||
| 07/08/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.16 | General |
| Category: AED | ||||||
| 06/25/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $63.42 | General |
| Category: CNS | ||||||
| 06/24/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $3.73 | General |
| Category: AED | ||||||
| 06/17/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $3.34 | General |
| Category: AED | ||||||
| 05/20/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $5.39 | General |
| Category: AED | ||||||
| 05/13/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $4.50 | General |
| Category: AED | ||||||
| 04/30/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: CNS | ||||||
| 04/29/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $6.55 | General |
| Category: AED | ||||||
| 04/22/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $6.65 | General |
| Category: AED | ||||||
| 04/10/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $5.60 | General |
| Category: AED | ||||||
| 04/03/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.11 | General |
| Category: AED | ||||||
| 03/27/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $5.54 | General |
| Category: AED | ||||||
| 03/20/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $5.12 | General |
| Category: AED | ||||||
| 03/13/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $9.85 | General |
| Category: AED | ||||||
| 03/11/2019 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: CNS | ||||||
| 03/06/2019 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $5.12 | General |
| Category: AED | ||||||
| 02/13/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $7.22 | General |
| Category: AED | ||||||
| 01/23/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $10.22 | General |
| Category: AED | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 117 | 168 | $37,007 | $10,530 |
| 2020 | 10 | 281 | 345 | $71,096 | $19,163 |
Total Patients
398
Total Services
513
Medicare Billing
$29,693
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 105 | 156 | $33,654 | $9,616 | 28.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $3,353 | $913.20 | 27.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 137 | 198 | $36,644 | $9,379 | 25.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 28 | 28 | $11,599 | $3,521 | 30.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 21 | $5,684 | $1,738 | 30.6% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 14 | 15 | $3,507 | $1,164 | 33.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $3,813 | $1,131 | 29.7% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2020 | 15 | 15 | $5,572 | $1,076 | 19.3% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Office | 2020 | 12 | 12 | $1,799 | $594.08 | 33.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 12 | 12 | $1,364 | $363.78 | 26.7% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 15 | 16 | $1,001 | $153.77 | 15.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 13 | 14 | $112.00 | $41.82 | 37.3% |
About Dr. William Malzone, M.D
Dr. William Malzone, M.D is a Neurology healthcare provider based in Lakeland, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982609434.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Malzone, M.D has received a total of $1,264 in payments from pharmaceutical and medical device companies, with $117.89 received in 2020. These payments were reported across 102 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($1,234).
As a Medicare-enrolled provider, Malzone has provided services to 398 Medicare beneficiaries, totaling 513 services with total Medicare billing of $29,693. Data is available for 2 years (2020–2021), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Lakeland, FL
- Active Since 06/20/2005
- Last Updated 11/25/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1982609434
Products in Payments
- TROKENDI XR (Drug) $384.72
- COPAXONE (Drug) $239.98
- NAMZARIC (Drug) $146.29
- NAMENDA XR (Drug) $139.42
- AUSTEDO (Drug) $119.99
- OXTELLAR XR (Drug) $103.46
- APTIOM (Drug) $99.67
- VRAYLAR (Drug) $29.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lakeland
Niraja Suresh, M.d, M.D
Neurology — Payments: $94,432
Neurology $94,432
Zuleyma Toledo-Nieves
Neurology — Payments: $83,197
Neurology $83,197
Karla Ledoux, Do, DO
Neurology — Payments: $35,704
Neurology $35,704
Daniel Traviesa, Md, MD
Neurology — Payments: $17,141
Neurology $17,141
Daynet Hisley, Md, MD
Neurology — Payments: $14,647
Neurology $14,647
Dr. Herminio Cuervo-Delgado, M.d, M.D
Neurology — Payments: $8,088
Neurology $8,088